Intensive Care of Pediatric Poisoning Cases

  • Prashant JoshiEmail author
  • Mitchell P. Ross
Reference work entry


According to the National Poison Data System (NPDS) of the American Association of Poison Control Centers, in 2014 poisoning in children under the age of 20 accounted for 61% of calls to poison centers in the United States [1]. The proportion of those cases that required referral to a health care facility (HCF) varied. 12.7% of children ≤5 years and only 16.5% of children between 6 and 12 years were managed in an HCF compared to 61.1% of teenagers (13–19 years). The proportion of children described as having a “Major Effect” rose from 0.07% in the under 5 age group to 1.65% in teenagers. The fatality rate was highest in the teen group (0.05%), where more than one half of ingestions are intentional versus the under 5 age group (<0.002%) where 99.5% of exposures are unintentional. The number of pediatric deaths among cases reported to US poison centers was 88. These figures have remained consistent over the past several years.


  1. 1.
    Mowry JB, Spyker DA, Brooks DE, Naya McMillan MS, Schauben JL. 2014 annual report of the American association of poison control centers’ National Poison Data System (NPDS): 32nd annual report. Clin Toxicol. 2015;53(10):962–1147.CrossRefGoogle Scholar
  2. 2.
    Lamireau T, Llanas B, Kennedy A, Fayon M, Penouil F, Favarell-Garrigues JC, Demarquez JL. Epidemiology of poisoning in children: a 7-year survey in a paediatric emergency care unit. Eur J Emerg Med. 2002;9(1):9–14.CrossRefPubMedGoogle Scholar
  3. 3.
    Lacroix J, Gaudreault P, Gauthier M. Admission to a pediatric intensive care unit for poisoning: a review of 105 cases. Crit Care Med. 1989;17(8):748–50.CrossRefPubMedGoogle Scholar
  4. 4.
    Even KM, Armsby CC, Bateman ST. Poisonings requiring admission to the pediatric intensive care unit: a 5-year review. Clin Toxicol (Phila). 2014;52(5):519–24.CrossRefGoogle Scholar
  5. 5.
    Höjer J, Troutman WG, Hoppu K, Erdman A, Benson BE, Mégarbane B, Thanacoody R, Bedry R, Caravati EM, American Academy of Clinical Toxicology, European Association of Poison Centres and Clinical Toxicologists. Position paper update: ipecac syrup for gastrointestinal decontamination. Clin Toxicol (Phila). 2013;51(3):134–9.CrossRefGoogle Scholar
  6. 6.
    American Academy of Clinical Toxicology & European Association of Poisons Centres and Clinical Toxicologists. Position paper: single-dose activated charcoal. Clin Toxicol. 2005;43(2):61–87.CrossRefGoogle Scholar
  7. 7.
    Banner Jr W. Concepts in toxicology review. Med Toxicol. 1986;1:225–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Banner Jr W, Timmons OD, Vernon DD. Advances in the critical care of poisoned paediatric patients. Drug Saf. 1994;10:83–92.CrossRefPubMedGoogle Scholar
  9. 9.
    Franck G, Sadzot B, Salmon E, et al. Regional cerebral blood flow and metabolic rates in human focal epilepsy and status epilepticus. Adv Neurol. 1986;44:935–48.PubMedGoogle Scholar
  10. 10.
    Chamberlain JM, Okada P, Holsti M, Mahajan P, Brown KM, Vance C, Gonzalez V, Lichenstein R, Stanley R, Brousseau DC, Grubenhoff J, Zemek R, Johnson DW, Clemons TE, Baren J, Pediatric Emergency Care Applied Research Network (PECARN). Lorazepam vs diazepam for pediatric status epilepticus: a randomized clinical trial. JAMA. 2014;311(16):1652–60.CrossRefPubMedGoogle Scholar
  11. 11.
    Cock HR, Schapira AH. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002;95(4):225–31.CrossRefPubMedGoogle Scholar
  12. 12.
    Prasad K, Krishnan PR, Al-Roomi K, Sequeira R. Anticonvulsant therapy for status epilepticus. Br J Clin Pharmacol. 2007;63(6):640–7.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Shah AS, Eddleston M. Should phenytoin or barbiturates be used as second-line anticonvulsant therapy for toxicological seizures? Clin Toxicol (Phila). 2010;48(8):800–5.CrossRefGoogle Scholar
  14. 14.
    McCabe JL, Cobaugh DJ, Menegazzi JJ, Fata J. Experimental tricyclic antidepressant toxicity: a randomized, controlled comparison of hypertonic saline solution, sodium bicarbonate, and hyperventilation. Ann Emerg Med. 1998;32(3 Pt 1):329–33.CrossRefPubMedGoogle Scholar
  15. 15.
    Liebelt EL. Targeted management strategies for cardiovascular toxicity from tricyclic antidepressant overdose: the pivotal role for alkalinization and sodium loading. Pediatr Emerg Care. 1998;14:293–8.CrossRefPubMedGoogle Scholar
  16. 16.
    Hoffman JR, Votey SR, Bayer M, et al. Effect of hypertonic sodium bicarbonate in the treatment of moderate-to-severe cyclic antidepressant overdose. Am J Emerg Med. 1993;11:336–41.CrossRefPubMedGoogle Scholar
  17. 17.
    Bradberry SM, Thanacoody HKR, Watt BE, et al. Management of the cardiovascular complications of tricyclic antidepressant poisoning: role of sodium bicarbonate. Toxicol Rev. 2005;24:195–204.CrossRefPubMedGoogle Scholar
  18. 18.
    Kim SY, Benowitz N. Poisoning due to class IA antiarrhythmic drugs: quinidine, procainamide and disopyramide. Drug Saf. 1990;5:393–420.CrossRefPubMedGoogle Scholar
  19. 19.
    Thomas SH, Behr ER. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol. 2016;81(3):420–7.CrossRefPubMedGoogle Scholar
  20. 20.
    Othong R, Devlin JJ, Kazzi ZN. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region. Clin Toxicol (Phila). 2015;53(4):204–9.CrossRefGoogle Scholar
  21. 21.
    Yamanaka K, Kitahata H, Tanaka K, et al. Intraoperative transesophageal ventricular pacing in pediatric patients. J Cardiothorac Vasc Anesth. 2008;22(1):92–4.CrossRefPubMedGoogle Scholar
  22. 22.
    de Caen AR, Berg MD, Chameides L, Gooden CK, Hickey RW, Scott HF, Sutton RM, Tijssen JA, Topjian A, van der Jagt ÉW, Schexnayder SM, Samson RA. Part 12: Pediatric advanced life support: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132:S526–42.CrossRefPubMedGoogle Scholar
  23. 23.
    The Pediatric Acute Lung Injury Consensus Conference Group. Pediatric acute respiratory distress syndrome: consensus recommendations from the pediatric acute lung injury consensus conference. Pediatr Crit Care Med. 2015;16:428–39.CrossRefPubMedCentralGoogle Scholar
  24. 24.
    Hickling KG, Walsh J, Henderson S, Jackson R. Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited ventilation with permissive hypercapnia: a prospective study. Crit Care Med. 1994;22:1568–78.CrossRefPubMedGoogle Scholar
  25. 25.
    Curley G, Hayes M, Laffley JG. Can 'permissive' hypercapnia modulate the severity of sepsis-induced ALI/ARDS? Crit Care. 2011;15:212–20.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Arnold JH, Hanson JH, Toro-Figuero LO, et al. Prospective, randomized comparison of high-frequency oscillatory ventilation and conventional mechanical ventilation in pediatric respiratory failure. Crit Care Med. 1994;22:1530–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Dysart K, Miller TL, Wolfson MR, Shaffer TH. Research in high flow therapy: mechanisms of action. Respir Med. 2009;103(10):1400–5.CrossRefPubMedGoogle Scholar
  28. 28.
    Linton DM. Cuirass ventilation: a review and update. Crit Care Resusc. 2005;7(1):22–8.PubMedGoogle Scholar
  29. 29.
    Deep A, De Munter C, Desai A. Negative pressure ventilation in pediatric critical care setting. Indian J Pediatr. 2007;74(5):483–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Algren DA, Ashworth A. Acute acepromazine overdose: clinical effects and toxicokinetic evaluation. J Med Toxicol. 2015;11:121–3.CrossRefPubMedGoogle Scholar
  31. 31.
    Shrivastava MS, Palkar AV, Karnik ND. Hydrocarbon pneumonitis masquerading as acute lung injury. BMJ Case Rep. 2011;pii:bcr0320114017 (published online 2011 Jul 15).Google Scholar
  32. 32.
    Shetty K, Sherif L, Babu R, Bhatt G. Noninvasive ventilation in a patient with noncardiogenic pulmonary edema following amlodipine poisoning. J Anaesthesiol Clin Pharmacol. 2015;31:264–6.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Kane DA, Thiagarajan RR, Wypij D, Scheurer MA, Fynn-Thompson F, Emani S, del Nido PJ, Betit P, Laussen PC. Rapid-response extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in children with cardiac disease. Circulation. 2010;122:S241–8.CrossRefPubMedGoogle Scholar
  34. 34.
    de Lange DW, Sikma MA, Meulenbelt J. Extracorporeal membrane oxygenation in the treatment of poisoned patients. Clin Toxicol (Phila). 2013;51(5):385–93.CrossRefGoogle Scholar
  35. 35.
    Wang GS, Levitan R, Wiegand TJ, Lowry J, Schult RF, Yin S, Toxicology Investigators Consortium. Extracorporeal Membrane Oxygenation (ECMO) for severe toxicological exposures: review of the Toxicology Investigators Consortium (ToxIC). J Med Toxicol. 2016;12(1):95–9.CrossRefPubMedGoogle Scholar
  36. 36.
    Nakagawa TA, Stephen A, Mudit M, Stephen A, Mudit M, Mysore MR, Derek B, Conway EE, Duthie SE, Shannon H, Rick H, Kline AM, Lebovitz DJ, Madden MA, Montgomery VL, Perlman JM, Nancy R, Shemie SD, Amit V, Williams-Phillips JA, Society of Critical Care Medicine, The Section on Critical Careand Section on Neurology of the American Academy of Pediatrics, The Child Neurology Society. Guidelines for the determination of brain death in infants andchildren: an update of the 1987 Task Force recommendations. Pediatrics. 2011;128:e720.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Paul L. Foster School of MedicineTexas Tech University Health Sciences Center El PasoEl PasoUSA
  2. 2.Critical Care MedicineProvidence Pediatric Intensive Care Unit St VincentPortlandUSA

Personalised recommendations